Hao B, Ma K, Xu J, Fan R, Zhao W, Jia X
Acta Pharmacol Sin. 2024; 45(6):1305-1315.
PMID: 38383757
PMC: 11130134.
DOI: 10.1038/s41401-024-01236-5.
Krushkal J, Zhao Y, Roney K, Zhu W, Brooks A, Wilsker D
Epigenetics. 2024; 19(1):2309824.
PMID: 38369747
PMC: 10878021.
DOI: 10.1080/15592294.2024.2309824.
Elbatrawy O, Hagras M, El Deeb M, Agili F, Hegazy M, El-Husseiny A
Pharmaceuticals (Basel). 2023; 16(7).
PMID: 37513878
PMC: 10384246.
DOI: 10.3390/ph16070966.
Yang J, Song C, Zhan X
Front Endocrinol (Lausanne). 2022; 13:972312.
PMID: 36171897
PMC: 9510633.
DOI: 10.3389/fendo.2022.972312.
Islam S, Espitia C, Persky D, Carew J, Nawrocki S
Blood Adv. 2020; 4(20):5297-5310.
PMID: 33108458
PMC: 7594386.
DOI: 10.1182/bloodadvances.2020002297.
Epigenetic Targeting of Autophagy via HDAC Inhibition in Tumor Cells: Role of p53.
Mrakovcic M, Bohner L, Hanisch M, Frohlich L
Int J Mol Sci. 2018; 19(12).
PMID: 30544838
PMC: 6321134.
DOI: 10.3390/ijms19123952.
Reversal of Resistance in Targeted Therapy of Metastatic Melanoma: Lessons Learned from Vemurafenib (BRAF-Specific Inhibitor).
Torres-Collado A, Knott J, Jazirehi A
Cancers (Basel). 2018; 10(6).
PMID: 29795041
PMC: 6025215.
DOI: 10.3390/cancers10060157.
BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma.
Paoluzzi L, Hanniford D, Sokolova E, Osman I, Darvishian F, Wang J
Cancer Med. 2016; 5(6):1183-93.
PMID: 27169980
PMC: 4867668.
DOI: 10.1002/cam4.667.
Oncogenic K-ras confers SAHA resistance by up-regulating HDAC6 and c-myc expression.
Wang Q, Tan R, Zhu X, Zhang Y, Tan Z, Su B
Oncotarget. 2016; 7(9):10064-72.
PMID: 26848526
PMC: 4891104.
DOI: 10.18632/oncotarget.7134.
Histone acetylation and reactive oxygen species are involved in the preprophase arrest induced by sodium butyrate in maize roots.
Zhang Q, Wang P, Hou H, Zhang H, Tan J, Huang Y
Protoplasma. 2016; 254(1):167-179.
PMID: 26781092
DOI: 10.1007/s00709-015-0928-9.
Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy.
Gallagher S, Tiffen J, Hersey P
Cancers (Basel). 2015; 7(4):1959-82.
PMID: 26426052
PMC: 4695870.
DOI: 10.3390/cancers7040870.
Inhibition of mouse B16 melanoma by sodium butyrate correlated to tumor associated macrophages differentiation suppression.
Xiong F, Mou Y, Xiang X
Int J Clin Exp Med. 2015; 8(3):4170-4.
PMID: 26064327
PMC: 4443161.
Trek1 contributes to maintaining nasal epithelial barrier integrity.
Jiang J, Liu J, Li J, Li M, Chen H, Yan H
Sci Rep. 2015; 5:9191.
PMID: 25778785
PMC: 7365316.
DOI: 10.1038/srep09191.
Eradication of metastatic melanoma through cooperative expression of RNA-based HDAC1 inhibitor and p73 by oncolytic adenovirus.
Schipper H, Alla V, Meier C, Nettelbeck D, Herchenroder O, Putzer B
Oncotarget. 2014; 5(15):5893-907.
PMID: 25071017
PMC: 4171600.
DOI: 10.18632/oncotarget.1839.
Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide).
Xia C, Leon-Ferre R, Laux D, Deutsch J, Smith B, Frees M
Cancer Chemother Pharmacol. 2014; 74(4):691-7.
PMID: 25062770
PMC: 4175037.
DOI: 10.1007/s00280-014-2501-1.
Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications.
Li Z, Zhu W
Int J Biol Sci. 2014; 10(7):757-70.
PMID: 25013383
PMC: 4081609.
DOI: 10.7150/ijbs.9067.
Targeting tumour-supportive cellular machineries in anticancer drug development.
Dobbelstein M, Moll U
Nat Rev Drug Discov. 2014; 13(3):179-96.
PMID: 24577400
DOI: 10.1038/nrd4201.
SAMSN1 is highly expressed and associated with a poor survival in glioblastoma multiforme.
Yan Y, Zhang L, Xu T, Zhou J, Qin R, Chen C
PLoS One. 2013; 8(11):e81905.
PMID: 24278465
PMC: 3838348.
DOI: 10.1371/journal.pone.0081905.
Transmembrane voltage potential is an essential cellular parameter for the detection and control of tumor development in a Xenopus model.
Chernet B, Levin M
Dis Model Mech. 2013; 6(3):595-607.
PMID: 23471912
PMC: 3634644.
DOI: 10.1242/dmm.010835.
Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance.
Dupere-Richer D, Kinal M, Menasche V, Nielsen T, Del Rincon S, Pettersson F
Cell Death Dis. 2013; 4:e486.
PMID: 23392174
PMC: 3734816.
DOI: 10.1038/cddis.2012.210.